Free cholesterol-induced cytotoxicity: A possible contributing factor to macrophage foam cell necrosis in advanced atherosclerotic lesions

Trends in Cardiovascular Medicine

Volumn 7, Issue 7, 1997, Pages 256-263

  Tabas, Ira ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ANIMAL CELL; ANIMAL MODEL; ATHEROSCLEROSIS; CELL DEATH; CELL ULTRASTRUCTURE; CYTOPATHOGENIC EFFECT; FOAM CELL; HISTOPATHOLOGY; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SHORT SURVEY;

EID: 0030685812     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(97)00086-8     Document Type: Review

References (62)

1. Arends MJ, Wyllie AH Apoptosis: mechanisms and roles in pathology. Int Rev Exp Path. 32:1991;223-254.
2. Arias-Daz J, Vara E, Garca Cet al. Tumor necrosis factor-a-induced inhibition of phosphatidylcholine synthesis by human type II pneumocytes is partially mediated by prostaglandins. J Clin Invest. 94:1994;244-250.
3. Atger VM, de la Llera Moya M, Stoudt GWet al. Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells. J Clin Invest. 99:1997;773-780.
4. Ball RY, Stowers EC, Burton JHet al. Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. Atherosclerosis. 114:1995;45-54.
5. Berberian PA, Myers W, Tytell Met al. Immunohistochemical localization of heat shock protein-70 in normal-appearing and atherosclerotic specimens of human arteries. Am J Pathol. 136:1990;71-80.
6. Breslow JL Lipoprotein metabolism and atherosclerosis susceptibility in transgenic mice. Curr Opin Lipidol. 5:1994;175-184.
7. Bretscher MS, Munro S Cholesterol and the Golgi apparatus. Science. 261:1993;1280-1281.
8. Brown MS, Ho YK, Goldstein JL The cholesteryl ester cycle in macrophage foam cells: Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters. J Biol Chem. 255:1980;9344-9352.
9. Clare K, Hardwick SJ, Carpenter KLet al. Toxicity of oxysterols to human monocyte-macrophages. Atherosclerosis. 118:1995;67-75.
10. Coffey MD, Cole RA, Colles SMet al. In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals. J Clin Invest. 96:1995;1866-1873.
11. Dawidowicz EA Dynamics of membrane lipid metabolism and turnover. Annu Rev Biochem. 56:1987;43-61.
12. Fielding CJ Lipoprotein receptors, plasma cholesterol metabolism, and the regulation of cellular free cholesterol concentration. FASEB J. 6:1992;3162-3168.
13. Fuster V, Badimon L, Badimon JJet al. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 326:1992;242-250.
14. Gelissen IC, Brown AJ, Mander ELet al. Sterol efflux is impaired from macrophage foam cells selectively enriched with 7-keto-cholesterol. J Biol Chem. 271:1996;17,852-17,860.
15. Geng Y, Libby P Evidence for apoptosis in advanced human atheroma: colocalization with interleukin-1b-converting enzyme. Am J Pathol. 147:1995;251-266.
16. Guyton JR, Klemp KF Development of the lipid-rich core in human atherosclerosis. Arterioscler Thromb Vasc Biol. 16:1996;4-11.
17. Heinle H Metabolite concentration gradients in the arterial wall of experimental atherosclerosis. Exp Mol Pathol. 46:1987;312-320.
18. Heughan U, Niinikoski J, Hunt K Oxygen tension in lesions of experimental atherosclerosis of rabbits. Atherosclerosis. 17:1973;361-367.
19. Hulten LM, Lindmark H, Diczfalusy Uet al. Oxysterols present in atherosclerotic tissue decrease the expression of lipoprotein lipase messenger RNA in human monocyte-derived macrophages. J Clin Invest. 97:1996;461-468.
20. Jackson RL, Gotto AM Jr. Hypothesis concerning membrane structure, cholesterol, and atherosclerosis. Ather Rev. 1:1976;1-21.
21. Jerome WG, Lewis JC Early atherogenesis in White Carneau pigeons. II. Ultrastructural and cytochemical observations Am J Pathol. 119:1985;210-222.
22. Kilsdonk EPC, Morel DW, Johnson WJet al. Inhibition of cellular cholesterol efflux by 25-hydroxycholesterol. J Lipid Res. 36:1995;505-516.
23. Lange Y, Swaisgood MH, Ramos BVet al. Plasma membranes contain half the phospholipid and 90% of the cholesterol and sphingomyelin in cultured human fibroblasts. J Biol Chem. 264:1989;3786-3793.
24. Libby P, Clinton SK The role of macrophages in atherogenesis. Curr Opin Lipidol. 4:1993;355-363.
25. Lund E, Andersson O, Zhang Jet al. Importance of a novel oxidative mechanism for elimination of intracellular cholesterol in humans. Arterioscler Thromb Vasc Biol. 16:1996;208-212.
26. Lundberg B Chemical composition and physical state of lipid deposits in atherosclerosis. Atherosclerosis. 56:1985;93-110.
27. Luu B, Moog C Oxysterols: biological activities and physicochemical studies. Biochimie. 73:1991;1317-1320.
28. Maor I, Mandel H, Aviram M Macrophage uptake of oxidized LDL inhibits lysosomal sphingomyelinase, thus causing the accumulation of unesterified cholesterol-sphingomyelin-rich particles in the lysosomes: a possible role for 7-ketocholesterol. Arterioscler Thromb Vasc Biol. 15:1995;1378-1387.
29. Mattsson L, Bondjers G, Wiklund O Isolation of cell populations from arterial tissue, using monoclonal antibodies and magnetic microspheres. Atherosclerosis. 89:1991;25-34.
30. McGookey DJ, Anderson RGW Morphological characterization of the cholesteryl ester cycle in cultured mouse macrophage foam cells. J Cell Biol. 97:1983;1156-1168.
31. Mitchinson MJ, Hardwick SJ, Bennett MR Cell death in atherosclerotic plaques. Curr Opin Lipidol. 7:1996;324-329.
32. Morin RJ, Peng SK The role of cholesterol oxidation products in the pathogenesis of atherosclerosis. Ann Clin Lab Sci. 19:1989;225-237.
33. Nagano Y, Arai H, Kita T High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc Natl Acad Sci USA. 88:1991;6457-6461.
34. Papahadjopoulos D Cholesterol and cell membrane function: a hypothesis concerning the etiology of atherosclerosis. J Theor Biol. 43:1974;329-337.
35. Rapp JH, Connor WE, Lin DSet al. Lipids of human atherosclerotic plaques and xanthomas: clues to the mechanism of plaque progression. J Lipid Res. 24:1983;1329-1335.
36. Ross R The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362:1993;801-809.
37. Rothberg KG, Ying YS, Kamen BAet al. Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltetrahydrofolate. J Cell Biol. 111(2):1990;2931-2938.
38. Salmon WD, Newberne PM Cardiovascular disease in choline-deficient rats. Arch Pathol Lab Med. 73:1962;190-209.
39. Schmitz G, Beuck M, Fischer Het al. Regulation of phospholipid biosynthesis during cholesterol influx and high density lipoprotein-mediated cholesterol efflux in macrophages. J Lipid Res. 31:1990;1741-1752.
40. Schroeder F, Jefferson JR, Kier ABet al. Membrane cholesterol dynamics: cholesterol domains and kinetic pools. Proc Soc Exp Biol Med. 196:1991;235-252.
41. Shio H, Haley NJ, Fowler S Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. II. Morphometric analysis of lipid-filled lysosomes and lipid droplets in aortic cell populations Lab Invest. 39:1978;390-397.
42. Shio H, Haley NJ, Fowler S Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. III. Intracellular localization of cholesterol and cholesteryl ester Lab Invest. 41:1979;160-167.
43. Shiratori Y, Okwu AK, Tabas I Free cholesterol loading of macrophages stimulates phosphatidylcholine biosynthesis and up-regulation of CTP:phosphocholine cytidylyltransferase. J Biol Chem. 269:1994;11,337-11,348.
44. Shiratori Y, Houweling M, Zha Xet al. Stimulation of CTP:phosphocholine cytidylyltransferase by free cholesterol loading of macrophages involves signalling through protein dephosphorylation. J Biol Chem. 270:1995;29,894-29,903.
45. Small DM Progression and regression of atherosclerotic lesions. Arteriosclerosis. 8:1988;103-129.
46. Small DM, Bond MG, Waugh Det al. Physicochemical and histological changes in the arterial wall of nonhuman primates during progression and regression of atherosclerosis. J Clin Invest. 73:1984;1590-1605.
47. Smith LL, Johnson BH Biological activities of oxysterols. Free Radical Biol Med. 7:1989;285-332.
48. Steinberg D, Parthasarathy S, Carew TEet al. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 320:1989;915-924.
49. Steller H Mechanisms and genes of cellular suicide. Science. 267:1995;1445-1449.
50. Tabas I The stimulation of the cholesterol esterification pathway by atherogenic lipoproteins in macrophages. Curr Opin Lipidol. 6:1995;260-268.
51. Tabas I Phospholipid metabolism in cholesterol-loaded macrophages. Curr Opin Lipidol. 8:1997;. (in press).
52. Tabas I, Marathe S, Keesler GAet al. Evidence that the initial up-regulation of phosphatidylcholine biosynthesis in free cholesterol-loaded macrophages is an adaptive response that prevents cholesterol-induced cellular necosis: proposed role of an eventual failure of this response in foam cell necrosis in advanced atherosclerosis. J Biol Chem. 271:1996;22,773-22,781.
53. Tangirala RK, Mahlberg FH, Glick JMet al. Lysosomal accumulation of unesterified cholesterol in model macrophage foam cells. J Biol Chem. 268:1993;9653-9660.
54. Tangirala RK, Jerome WG, Jones NLet al. Formation of cholesterol monohydrate crystals in macrophage-derived foam cells. J Lipid Res. 35:1994;93-104.
55. Tsukada T, Rosenfeld M, Ross Ret al. Immunocytochemical analysis of cellular components in atherosclerotic lesions: use of monoclonal antibodies with the Watanabbe and fat-fed rabbit. Atherosclerosis. 6:1986;601-613.
56. van Meer G Lipid traffic in animal cells. Annu Rev Cell Biol. 5:1989;247-275.
57. Warner GJ, Stoudt G, Bamberger M Cell toxicity induced by inhibition of acyl coenzyme A: cholesterol acyltransferase and accumulation of unesterified cholesterol. J Biol Chem. 270:1995;5772-5778.
58. Warnock DE, Roberts C, Lutz MS Determination of plasma membrane lipid mass and composition in cultured Chinese hamster ovary cells using high gradient magnetic affinity chromatography. J Biol Chem. 268:1993;10,145-10,153.
59. Weltzien HU Cytolytic and membrane-perturbing properties of lysophosphatidyl-choline. Biochim Biophys Acta. 559:1979;259-287.
60. Williams KJ, Tabas I The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol. 15:1995;551-561.
61. Yeagle PL Cholesterol and the cell membrane. Biochim Biophys Acta. 822:1985;267-287.
62. Yeagle PL Modulation of membrane function by cholesterol. Biochimie. 73:1991;1303-1310.